Leucemia: Diretrizes Médicas (Leukemia: Guidelines)

■ American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

Mikkael A. Sekeres, Gordon Guyatt, Gregory Abel et al

Blood Adv. 2020 Aug 11; 4(15): 3528–3549

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422124/

■ Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia

Jorge E. Cortes, Marcos de Lima, Hervé Dombret, et al

J Hematol Oncol. 2020; 13: 137.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559451/

■ Recent drug approvals for acute myeloid leukemia

Catherine Lai, Kimberley Doucette, Kelly Norsworthy

J Hematol Oncol. 2019; 12: 100.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749668/

■ Validation and refinement of the revised ,2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

Tobias Herold, Maja Rothenberg-Thurley, Victoria V. Grunwald et al

Leukemia. 2020; 34(12): 3161–3172

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685975/

■ Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Ali Bazarbachi, Gesine Bug, Frederic Baron et al

Haematologica. 2020 Jun; 105(6): 1507–1516

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271578/

■ CAR T cells for acute myeloid leukemia: state of the art and future directions

Sherly Mardiana, Saar Gill

Front Oncol. 2020; 10: 697

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218049/

■ Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL – ERIC recommendations.

Zalcberg, Ilana et al.

Hematol., Transfus. Cell Ther., Sept 2020, vol.42, no.3, p.269-274

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792020000300269&lng=pt&nrm=iso

■ European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Hochhaus, M. Baccarani, R. T. Silver et al

Leukemia. 2020; 34(4): 966–984

https://www.nature.com/articles/s41375-020-0776-2

■ Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute

Maribel Parra, Maria Joao Baptista, Eulàlia Genescà et al

Hematol Oncol. 2020 Oct; 38(4): 432–438

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687178/

■ Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

Bachar Samra, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Nicholas J. Short

J Hematol Oncol. 2020; 13: 70

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275444/

■ Expert opinion – management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors

Andreas Hochhaus, Massimo Breccia, Giuseppe Saglio et al

Leukemia. 2020; 34(6): 1495–1502

https://www.nature.com/articles/s41375-020-0842-9

■ European recommendations ad quality assurance for cytogenomic analysis of haematological neoplasms: response to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)